Kent Wallner

Summary

Country: USA

Publications

  1. ncbi request reprint 125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial
    Kent Wallner
    Department of Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA 98108, USA
    Int J Radiat Oncol Biol Phys 57:1297-303. 2003
  2. ncbi request reprint I-125 versus Pd-103 for low-risk prostate cancer: long-term morbidity outcomes from a prospective randomized multicenter controlled trial
    Andrew Herstein
    Department of Radiation Oncology, Seattle, Washington, USA
    Cancer J 11:385-9. 2005
  3. ncbi request reprint 20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: preliminary biochemical outcomes from a prospective randomized multi-center trial
    Kent Wallner
    Department of Veterans Affairs, Radiation Oncology, Puget Sound Health Care System, Seattle, WA 98108 1597, USA
    Radiother Oncol 75:307-10. 2005
  4. doi request reprint There is a wide range of predictive dosimetric factors for I-125 and pd-103 prostate brachytherapy
    Andrew Herstein
    Department of Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, Washington, USA
    Am J Clin Oncol 31:6-10. 2008
  5. ncbi request reprint Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy
    Jacques Corriveau
    Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA, USA
    Brachytherapy 2:108-13. 2003
  6. doi request reprint The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, WA 98195 6043, USA
    Am J Clin Oncol 31:231-6. 2008
  7. ncbi request reprint Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding
    Amy Mueller
    Radiation Oncology 174, Veterans Affairs Puget Sound Health Care System, 1660 S Columbian Way, Seattle, WA 98108 1597, USA
    Int J Radiat Oncol Biol Phys 59:1047-52. 2004
  8. ncbi request reprint Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer
    Tracy Sherertz
    Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, 1600 S Columbian Way, Seattle, WA 98108 1597, USA
    Brachytherapy 3:130-5. 2004
  9. ncbi request reprint Rectal fistulas after prostate brachytherapy
    Audrey Tran
    Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA
    Int J Radiat Oncol Biol Phys 63:150-4. 2005
  10. ncbi request reprint Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation
    Peter Orio
    Department of Radiation Oncology, University of Washington, Seattle, WA, USA
    Int J Radiat Oncol Biol Phys 67:342-6. 2007

Collaborators

Detail Information

Publications44

  1. ncbi request reprint 125I versus 103Pd for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial
    Kent Wallner
    Department of Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA 98108, USA
    Int J Radiat Oncol Biol Phys 57:1297-303. 2003
    ..To compare prostate cancer control rates in patients who received (125)I vs. (103)Pd...
  2. ncbi request reprint I-125 versus Pd-103 for low-risk prostate cancer: long-term morbidity outcomes from a prospective randomized multicenter controlled trial
    Andrew Herstein
    Department of Radiation Oncology, Seattle, Washington, USA
    Cancer J 11:385-9. 2005
    ..We tested the hypothesis that the shorter half-life of Pd-103 versus I-125 results in different late radiation-related morbidities following prostate brachytherapy...
  3. ncbi request reprint 20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: preliminary biochemical outcomes from a prospective randomized multi-center trial
    Kent Wallner
    Department of Veterans Affairs, Radiation Oncology, Puget Sound Health Care System, Seattle, WA 98108 1597, USA
    Radiother Oncol 75:307-10. 2005
    ..Similar to classic randomized Wilm's tumor studies from the 1980s, the intention of the trial design was to decrementally test the need for beam radiation...
  4. doi request reprint There is a wide range of predictive dosimetric factors for I-125 and pd-103 prostate brachytherapy
    Andrew Herstein
    Department of Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, Washington, USA
    Am J Clin Oncol 31:6-10. 2008
    ..We have analyzed biochemical control versus multiple dosimetric parameters for a relatively homogeneous group of low-risk patients treated with I-125 or Pd-103...
  5. ncbi request reprint Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy
    Jacques Corriveau
    Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA, USA
    Brachytherapy 2:108-13. 2003
    ..To determine if gap time variations between prostate brachytherapy and supplemental beam radiation (EBRT) affect postimplant morbidity...
  6. doi request reprint The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, WA 98195 6043, USA
    Am J Clin Oncol 31:231-6. 2008
    ..To determine whether treatment gap between supplemental beam radiation and brachytherapy implant affects rectal morbidity and likelihood of cure in the treatment of intermediate-risk prostate cancer...
  7. ncbi request reprint Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding
    Amy Mueller
    Radiation Oncology 174, Veterans Affairs Puget Sound Health Care System, 1660 S Columbian Way, Seattle, WA 98108 1597, USA
    Int J Radiat Oncol Biol Phys 59:1047-52. 2004
    ..To correlate rectal wall doses and perirectal seed numbers with late rectal bleeding after prostate brachytherapy...
  8. ncbi request reprint Factors predictive of rectal bleeding after 103Pd and supplemental beam radiation for prostate cancer
    Tracy Sherertz
    Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, 1600 S Columbian Way, Seattle, WA 98108 1597, USA
    Brachytherapy 3:130-5. 2004
    ..To evaluate the contribution of various clinical and radiation treatment parameters to the likelihood of late rectal bleeding after brachytherapy plus supplemental beam radiation (EB)...
  9. ncbi request reprint Rectal fistulas after prostate brachytherapy
    Audrey Tran
    Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA
    Int J Radiat Oncol Biol Phys 63:150-4. 2005
    ..To compare the rectal and prostatic radiation doses for a prospective series of 503 patients, 44 of whom developed persistent rectal bleeding, and 2 of whom developed rectal-prostatic fistulas...
  10. ncbi request reprint Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation
    Peter Orio
    Department of Radiation Oncology, University of Washington, Seattle, WA, USA
    Int J Radiat Oncol Biol Phys 67:342-6. 2007
    ..To analyze the role of dosimetric quality parameters in maximizing cancer eradication in higher risk prostate cancer patients treated with palladium (Pd)-103 and supplemental beam radiation...
  11. ncbi request reprint The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trials
    Maged Ghaly
    Department of Radiation Oncology, Methodist Hospital, New York, NY, USA
    Int J Radiat Oncol Biol Phys 55:1288-93. 2003
    ..To detail the effect of supplemental beam radiation on prostate brachytherapy-related morbidity...
  12. doi request reprint Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy
    L Christine Fang
    Department of Radiation Oncology, University of Washington Medical Center, Seattle, Washington 98195, USA
    Urology 71:146-50. 2008
    ....
  13. ncbi request reprint High-dose regions versus likelihood of cure after prostate brachytherapy
    Kent Wallner
    Department of Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA 98108 1597, USA
    Int J Radiat Oncol Biol Phys 62:170-4. 2005
    ..To analyze the effect of high-dose regions on biochemical cancer control rates after prostate brachytherapy...
  14. ncbi request reprint The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd 103 plus beam radiation therapy
    Tracy Sherertz
    Department of Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, Washington 98108, USA
    Cancer J 10:301-6. 2004
    ..Accordingly, we have analyzed the effect of pattern 5 cancer on the prognosis of prostate cancer treated with Pd-103 brachytherapy...
  15. ncbi request reprint The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapy
    Hiroki Mitsuyama
    Department of Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA 98108 1597, USA
    Am J Clin Oncol 30:597-600. 2007
    ..To determine the effect of high-grade prostate cancer (Gleason pattern 5) on the prognosis of patients treated with Pd-103 brachytherapy...
  16. ncbi request reprint Effect of post-implant edema on prostate brachytherapy treatment margins
    Daniel R Reed
    Radiation Oncology, Arizona Oncology Services, Phoenix, AZ 85260, USA
    Int J Radiat Oncol Biol Phys 63:1469-73. 2005
    ..To determine if postimplant prostate brachytherapy treatment margins calculated on Day 0 differ substantially from those calculated on Day 30...
  17. ncbi request reprint Optimized prostate brachytherapy minimizes the prognostic impact of percent of biopsy cores involved with adenocarcinoma
    Rizwan Nurani
    Department of Radiation Oncology, Puget Sound Health Care System, Seattle, Washington 98108 1597, USA
    J Urol 178:1968-73; discussion 1973. 2007
    ....
  18. ncbi request reprint Clinical correlates of high intraprostatic brachytherapy dose volumes
    Shaleah Jones
    Medical School, University of Washington, Seattle, USA
    Int J Radiat Oncol Biol Phys 53:328-33. 2002
    ..To determine if high intraprostatic dose regions correlate with postimplant urinary or rectal morbidity, potentially providing some objective basis for recommendations regarding dose homogeneity...
  19. ncbi request reprint Seed-based transrectal ultrasound-fluoroscopy registration method for intraoperative dosimetry analysis of prostate brachytherapy
    Ismail B Tutar
    Department of Electrical Engineering, Image Computing Systems Laboratory, University of Washington, Seattle, Washington 98195, USA
    Med Phys 35:840-8. 2008
    ..2 cm even when the seed detection rate is only 10%. We believe that IOA can offer a robust solution to seed-based TRUS-fluoroscopy registration, thus making intraoperative dosimetry possible...
  20. ncbi request reprint The effect of interobserver differences in post-implant prostate CT image interpretation on dosimetric parameters
    Ben H Han
    Department of Radiation Oncology, University of Washington, Seattle, Washington, USA
    Med Phys 30:1096-102. 2003
    ..The V100 and TMs are less influenced by interobserver CT interpretation variability than is the D90, and may be better suited as interinstitutional quality indices...
  21. ncbi request reprint Epididymitis after prostate brachytherapy
    S Christopher Hoffelt
    Department of Radiation Oncology, Oregon Health and Sciences University, Portland, Oregon, USA
    Urology 63:293-6. 2004
    ..To analyze the incidence, time-course, and potential predisposing factors for what was clinically diagnosed as postimplant epididymitis...
  22. ncbi request reprint Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy
    Daniel Reed
    Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington, USA
    Urology 62:683-8. 2003
    ..To make some preliminary observations regarding the biochemical characteristics of the doubly confusing picture of prostate-specific antigen (PSA) spikes and histologically positive biopsies after prostate brachytherapy...
  23. ncbi request reprint Modification of prostate implants based on postimplant treatment margin assessment
    Amy Mueller
    Department of Radiation Oncology, University of Washington, Seattle, Washington, USA
    Med Phys 29:2782-7. 2002
    ..To quantify the extent of additional source placement needed to perfect an implant after execution by standard techniques, assuming that uniform 5 mm treatment margins (TMs) is the criteria for perfection...
  24. ncbi request reprint Semiautomatic 3-D prostate segmentation from TRUS images using spherical harmonics
    Ismail B Tutar
    Image Computing Systems Laboratory, Departments of Electrical Engineering and Bioengineering, University of Washington, Seattle, WA 98195, USA
    IEEE Trans Med Imaging 25:1645-54. 2006
    ..The overall mean absolute distance error was 1.26 +/- 0.41 mm while the percent volume overlap was 83.5 +/- 4.2. We found the segmentation error to be slightly less than the clinically-observed interobserver variability...
  25. ncbi request reprint Reviving the acid phosphatase test for prostate cancer
    Al Taira
    Department of Radiation Oncology, University of Washington, Seattle, Washington 98195, USA
    Oncology (Williston Park) 21:1003-10. 2007
    ....
  26. ncbi request reprint Prostate brachytherapy under local anesthesia; lessons from the first 600 patients
    Kent Wallner
    Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA, USA
    Brachytherapy 1:145-8. 2002
    ..Local anesthesia for prostate brachytherapy was instituted at the Puget Sound Veterans Hospital in 1999, peforming the procedure in our own department without anesthesia personnel in attendance...
  27. ncbi request reprint I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial
    Kent Wallner
    Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, Washington 98108 1597, USA
    Cancer J 8:67-73. 2002
    ..The purpose of this study was to test the hypothesis that the shorter half-life of Pd-103 versus I-125 results in a shorter duration of radiation-related symptoms after prostate brachytherapy...
  28. ncbi request reprint A reappraisal of local anesthesia for prostate brachytherapy
    Amy Mueller
    Radiation Oncology, Puget Sound Health Care System, Department of Veterans Affairs, Seattle, WA 98108 1597, USA
    Radiother Oncol 67:309-12. 2003
    ....
  29. ncbi request reprint Gross hematuria after prostate brachytherapy
    Jerry Barker
    Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington, USA
    Urology 61:408-11. 2003
    ..To summarize the clinical course of postimplant gross hematuria occurring past the perioperative period...
  30. ncbi request reprint Prostate brachytherapy in obese patients
    Jason Rockhill
    Department of Radiation Oncology, University of Washington, Seattle, WA, USA
    Brachytherapy 1:54-60. 2002
    ..To identify and illustrate the potential problems with brachytherapy in obese patients...
  31. ncbi request reprint Medical malpractice of prostate brachytherapy
    Kathryn Elliott
    School of Law, University of Washington, Seattle, WA, USA
    Brachytherapy 3:231-6. 2004
    ..To summarize the basis for brachytherapy-associated legal complaints...
  32. ncbi request reprint Late urinary function after prostate brachytherapy
    Daniel Landis
    Department of Radiation Oncology, University of Washington, Seattle, WA, USA
    Brachytherapy 1:21-6. 2002
    ..To determine the relationship between short term and longer term morbidity following prostate brachytherapy...
  33. ncbi request reprint Chronic pelvic pain following prostate brachytherapy: a case report
    Kent Wallner
    Radiation Oncology 174, Department of Veterans Affairs, 1660 S Columbian Way, Seattle, WA 98108 1597, USA
    Brachytherapy 3:153-8. 2004
    ..To alert physicians and potential patients that chronic postimplant pelvic pain syndromes can occur, and that dosimetric parameters (i.e., implant technique) may predispose patients to it...
  34. ncbi request reprint Urinary morbidity in brachytherapy patients with median lobe hyperplasia
    Johnathan Nguyen
    School of Medicine, University of Washington, Seattle, WA, USA
    Brachytherapy 1:42-7. 2002
    ..To investigate clinical course of prostate brachytherapy patients with radiographic evidence of median lobe hyperplasia (MLH)...
  35. ncbi request reprint Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity
    Gregory S Merrick
    Schiffler Cancer Center, Wheeling Hospital, Wheeling, West Virginia 26003 6300, USA
    Urology 60:104-8. 2002
    ..The effect of obesity on dosimetric quality and biochemical outcome was also evaluated...
  36. ncbi request reprint Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study
    Jacob Locke
    Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63108, USA
    Int J Radiat Oncol Biol Phys 52:712-9. 2002
    ..We prospectively investigated prognostic factors for men undergoing transperineal radioactive seed implantation for prostate cancer at the University of Washington...
  37. ncbi request reprint Extraprostatic seed placement and its effect on seed loss
    Elena Nedea
    Department of Radiation Oncology, McGill University, Montreal, Quebec, Canada
    Cancer J 11:147-51. 2005
    ....
  38. ncbi request reprint Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features
    Michael Dattoli
    Dattoli Cancer Center and Brachytherapy Research Institute, Sarasota, Florida, USA
    Cancer 110:551-5. 2007
    ..This study summarizes long-term outcomes from treatment of prostate cancer with increased risk of extracapsular cancer extension (ECE) using brachytherapy-based treatment...
  39. ncbi request reprint Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy
    Gregory S Merrick
    Schiffler Cancer Center, Wheeling Hospital and Wheeling Jesuit University, Wheeling, WV 26003 6300, USA
    Eur Urol 52:715-23. 2007
    ..To determine the prostate cancer incidence, anatomic distribution, Gleason score profile, and tumor burden in patients diagnosed by transperineal template-guided saturation biopsy (TTSB)...
  40. ncbi request reprint Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension
    Michael Dattoli
    Dattoli Cancer Center and Brachytherapy Research Institute, Sarasota, Florida 34217, USA
    Urology 69:334-7. 2007
    ..To report the long-term biochemical control rates with brachytherapy-based treatment for patients with prostate cancer at high risk of extracapsular cancer extension...
  41. ncbi request reprint Long-term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma: influence of prostatic acid phosphatase
    Michael Dattoli
    Dattoli Cancer Center and Brachytherapy Research Institute, Sarasota, Florida 34237, USA
    Cancer 97:979-83. 2003
    ..The objective of this study was to define the long-term prognostic significance of prostatic acid phosphatase (PAP) levels in patients with higher risk, early-stage prostate carcinoma...
  42. ncbi request reprint MR imaging for prostate cancer staging: beauty or beast?
    Kent Wallner
    Int J Radiat Oncol Biol Phys 52:886-7. 2002
  43. ncbi request reprint American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy
    Subir Nag
    American Brachytherapy Society, Oakbrook, IL, USA
    Int J Radiat Oncol Biol Phys 54:462-70. 2002
    ..To standardize the reporting of brachytherapy-related prostate morbidity to guide ongoing clinical practice and future investigations...
  44. ncbi request reprint Factors affecting patient selection for prostate brachytherapy: what nurses should know
    Debra Zeroski
    Clin J Oncol Nurs 9:553-60. 2005
    ..Clinical studies seek to further define patient selection criteria and examine optimal choices for adjuvant treatment and isotope preference. Expanding the knowledge base of nurses helps enhance patient care...